Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: High mortality due to pulmonary hemorrhage

K. Tada, S. Kurosawa, N. Hiramoto, K. Okinaka, N. Ueno, Y. Asakura, S. W. Kim, T. Yamashita, S. I. Mori, Y. Heike, A. M. Maeshima, Ryuji Tanosaki, K. Tobinai, T. Fukuda

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

To clarify the clinical features and outcome of Stenotrophomonas maltophilia infection among hematopoietic SCT (HCT) recipients, we retrospectively reviewed the records of 1085 consecutive HCT recipients and identified 42 episodes in 31 HCT recipients with S. maltophilia infection. We compared these recipients with 30 non-HCT patients with S. maltophilia infection. The mortality rate in HCT recipients was significantly higher than that in non-HCT patients (relative risk 5.7, P=0.04), and we identified seven patients with pulmonary hemorrhage due to S. maltophilia, exclusively in the HCT cohort. Six of these latter seven patients died within 1 day from the onset of hemorrhage and the isolate was identified after death in most cases; one patient, who received empiric therapy for S. maltophilia and granulocyte transfusion, survived for more than 2 weeks. The patients with pulmonary hemorrhage had a more severe and longer duration of neutropenia, persistent fever despite of the use of broad-spectrum antibiotics, complication by pneumonia and higher C-reactive protein levels than those without pulmonary hemorrhage. In conclusion, S. maltophilia was associated with fulminant and fatal pulmonary hemorrhage in HCT recipients. Empiric therapy with antibiotics before the onset of pulmonary hemorrhage may be effective in HCT recipients who carry the conditions identified.

Original languageEnglish
Pages (from-to)74-79
Number of pages6
JournalBone Marrow Transplantation
Volume48
Issue number1
DOIs
Publication statusPublished - 2013 Jan
Externally publishedYes

Fingerprint

Stenotrophomonas maltophilia
Hemorrhage
Lung
Mortality
Infection
Anti-Bacterial Agents
Neutropenia
Granulocytes
C-Reactive Protein
Pneumonia
Fever
Therapeutics

Keywords

  • Pulmonary hemorrhage
  • SCT
  • Stenotrophomonas maltophilia

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Stenotrophomonas maltophilia infection in hematopoietic SCT recipients : High mortality due to pulmonary hemorrhage. / Tada, K.; Kurosawa, S.; Hiramoto, N.; Okinaka, K.; Ueno, N.; Asakura, Y.; Kim, S. W.; Yamashita, T.; Mori, S. I.; Heike, Y.; Maeshima, A. M.; Tanosaki, Ryuji; Tobinai, K.; Fukuda, T.

In: Bone Marrow Transplantation, Vol. 48, No. 1, 01.2013, p. 74-79.

Research output: Contribution to journalArticle

Tada, K, Kurosawa, S, Hiramoto, N, Okinaka, K, Ueno, N, Asakura, Y, Kim, SW, Yamashita, T, Mori, SI, Heike, Y, Maeshima, AM, Tanosaki, R, Tobinai, K & Fukuda, T 2013, 'Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: High mortality due to pulmonary hemorrhage', Bone Marrow Transplantation, vol. 48, no. 1, pp. 74-79. https://doi.org/10.1038/bmt.2012.87
Tada, K. ; Kurosawa, S. ; Hiramoto, N. ; Okinaka, K. ; Ueno, N. ; Asakura, Y. ; Kim, S. W. ; Yamashita, T. ; Mori, S. I. ; Heike, Y. ; Maeshima, A. M. ; Tanosaki, Ryuji ; Tobinai, K. ; Fukuda, T. / Stenotrophomonas maltophilia infection in hematopoietic SCT recipients : High mortality due to pulmonary hemorrhage. In: Bone Marrow Transplantation. 2013 ; Vol. 48, No. 1. pp. 74-79.
@article{1a7d1c5f8fd7433a87ec8067b81baef3,
title = "Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: High mortality due to pulmonary hemorrhage",
abstract = "To clarify the clinical features and outcome of Stenotrophomonas maltophilia infection among hematopoietic SCT (HCT) recipients, we retrospectively reviewed the records of 1085 consecutive HCT recipients and identified 42 episodes in 31 HCT recipients with S. maltophilia infection. We compared these recipients with 30 non-HCT patients with S. maltophilia infection. The mortality rate in HCT recipients was significantly higher than that in non-HCT patients (relative risk 5.7, P=0.04), and we identified seven patients with pulmonary hemorrhage due to S. maltophilia, exclusively in the HCT cohort. Six of these latter seven patients died within 1 day from the onset of hemorrhage and the isolate was identified after death in most cases; one patient, who received empiric therapy for S. maltophilia and granulocyte transfusion, survived for more than 2 weeks. The patients with pulmonary hemorrhage had a more severe and longer duration of neutropenia, persistent fever despite of the use of broad-spectrum antibiotics, complication by pneumonia and higher C-reactive protein levels than those without pulmonary hemorrhage. In conclusion, S. maltophilia was associated with fulminant and fatal pulmonary hemorrhage in HCT recipients. Empiric therapy with antibiotics before the onset of pulmonary hemorrhage may be effective in HCT recipients who carry the conditions identified.",
keywords = "Pulmonary hemorrhage, SCT, Stenotrophomonas maltophilia",
author = "K. Tada and S. Kurosawa and N. Hiramoto and K. Okinaka and N. Ueno and Y. Asakura and Kim, {S. W.} and T. Yamashita and Mori, {S. I.} and Y. Heike and Maeshima, {A. M.} and Ryuji Tanosaki and K. Tobinai and T. Fukuda",
year = "2013",
month = "1",
doi = "10.1038/bmt.2012.87",
language = "English",
volume = "48",
pages = "74--79",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Stenotrophomonas maltophilia infection in hematopoietic SCT recipients

T2 - High mortality due to pulmonary hemorrhage

AU - Tada, K.

AU - Kurosawa, S.

AU - Hiramoto, N.

AU - Okinaka, K.

AU - Ueno, N.

AU - Asakura, Y.

AU - Kim, S. W.

AU - Yamashita, T.

AU - Mori, S. I.

AU - Heike, Y.

AU - Maeshima, A. M.

AU - Tanosaki, Ryuji

AU - Tobinai, K.

AU - Fukuda, T.

PY - 2013/1

Y1 - 2013/1

N2 - To clarify the clinical features and outcome of Stenotrophomonas maltophilia infection among hematopoietic SCT (HCT) recipients, we retrospectively reviewed the records of 1085 consecutive HCT recipients and identified 42 episodes in 31 HCT recipients with S. maltophilia infection. We compared these recipients with 30 non-HCT patients with S. maltophilia infection. The mortality rate in HCT recipients was significantly higher than that in non-HCT patients (relative risk 5.7, P=0.04), and we identified seven patients with pulmonary hemorrhage due to S. maltophilia, exclusively in the HCT cohort. Six of these latter seven patients died within 1 day from the onset of hemorrhage and the isolate was identified after death in most cases; one patient, who received empiric therapy for S. maltophilia and granulocyte transfusion, survived for more than 2 weeks. The patients with pulmonary hemorrhage had a more severe and longer duration of neutropenia, persistent fever despite of the use of broad-spectrum antibiotics, complication by pneumonia and higher C-reactive protein levels than those without pulmonary hemorrhage. In conclusion, S. maltophilia was associated with fulminant and fatal pulmonary hemorrhage in HCT recipients. Empiric therapy with antibiotics before the onset of pulmonary hemorrhage may be effective in HCT recipients who carry the conditions identified.

AB - To clarify the clinical features and outcome of Stenotrophomonas maltophilia infection among hematopoietic SCT (HCT) recipients, we retrospectively reviewed the records of 1085 consecutive HCT recipients and identified 42 episodes in 31 HCT recipients with S. maltophilia infection. We compared these recipients with 30 non-HCT patients with S. maltophilia infection. The mortality rate in HCT recipients was significantly higher than that in non-HCT patients (relative risk 5.7, P=0.04), and we identified seven patients with pulmonary hemorrhage due to S. maltophilia, exclusively in the HCT cohort. Six of these latter seven patients died within 1 day from the onset of hemorrhage and the isolate was identified after death in most cases; one patient, who received empiric therapy for S. maltophilia and granulocyte transfusion, survived for more than 2 weeks. The patients with pulmonary hemorrhage had a more severe and longer duration of neutropenia, persistent fever despite of the use of broad-spectrum antibiotics, complication by pneumonia and higher C-reactive protein levels than those without pulmonary hemorrhage. In conclusion, S. maltophilia was associated with fulminant and fatal pulmonary hemorrhage in HCT recipients. Empiric therapy with antibiotics before the onset of pulmonary hemorrhage may be effective in HCT recipients who carry the conditions identified.

KW - Pulmonary hemorrhage

KW - SCT

KW - Stenotrophomonas maltophilia

UR - http://www.scopus.com/inward/record.url?scp=84872128057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872128057&partnerID=8YFLogxK

U2 - 10.1038/bmt.2012.87

DO - 10.1038/bmt.2012.87

M3 - Article

C2 - 22635245

AN - SCOPUS:84872128057

VL - 48

SP - 74

EP - 79

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 1

ER -